GoodRx (GDRX) Stock: $49 Price Target From SVB Leerink

By Amit Chowdhry ● Nov 15, 2021
  • The shares of GoodRx Holdings Inc (NASDAQ: GDRX) have received a $49 price target from SVB Leerink. These are the details.

The shares of GoodRx Holdings Inc (NASDAQ: GDRX) have received a $49 price target from SVB Leerink. And SVB Leerink analyst Stephanie Davis reduced the price target from $56 while maintaining an “Outperform” rating on the shares.

Davis noted that the shares were down as an in-line quarter. And the narrowed guidance did not prove to be enough, especially in light of a holders base that leans more software/internet than the majority of her coverage universe.

And on the one hand, Davis is positive on GoodRx’s growth momentum and ability to execute within its originally guided ranges despite COVID headwinds. But on the other hand, Davis is cautious that the company’s full year 2021 guidance reflected a full return to pre-COVID normalcy as it suggests a far more aggressive guidance philosophy than peers.

Disclaimer: This content is intended for informational purposes. Before making any investment, you should do your own analysis.